313 related articles for article (PubMed ID: 17383932)
1. Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure--a population study.
Hudson M; Rahme E; Behlouli H; Sheppard R; Pilote L
Eur J Heart Fail; 2007; 9(6-7):602-9. PubMed ID: 17383932
[TBL] [Abstract][Full Text] [Related]
2. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
Gotsman I; Rubonivich S; Azaz-Livshits T
Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibitors and survival in women and men with heart failure.
Keyhan G; Chen SF; Pilote L
Eur J Heart Fail; 2007; 9(6-7):594-601. PubMed ID: 17462947
[TBL] [Abstract][Full Text] [Related]
4. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
Tsuchihashi-Makaya M; Furumoto T; Kinugawa S; Hamaguchi S; Goto K; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016
[TBL] [Abstract][Full Text] [Related]
5. The rationale and indications for angiotensin receptor blockers in heart failure.
Bybee KA; Das S; O'Keefe JH
Heart Fail Clin; 2006 Jan; 2(1):81-8. PubMed ID: 17386879
[No Abstract] [Full Text] [Related]
6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
[TBL] [Abstract][Full Text] [Related]
9. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
Ghanem FA; Movahed A
Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
[TBL] [Abstract][Full Text] [Related]
10. RAS blockers: Does sex matter? Re: Sex differences in the effectiveness of ARB and ACEI in patients with congestive heart failure - A population study: Marie Hudson et al. European Journal of Heart Failure 9 (2007) 602-609.
Strauss MH; Hall A
Eur J Heart Fail; 2007 Sep; 9(9):963-4; author reply 964. PubMed ID: 17669685
[No Abstract] [Full Text] [Related]
11. Sex differences in response to chronic heart failure therapies.
Ghali JK; Lindenfeld J
Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):555-65. PubMed ID: 18402544
[TBL] [Abstract][Full Text] [Related]
12. Comparison of angiotensin-converting enzyme inhibitors in the treatment of congestive heart failure.
Tu K; Mamdani M; Kopp A; Lee D
Am J Cardiol; 2005 Jan; 95(2):283-6. PubMed ID: 15642572
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
Grothusen A; Divchev D; Luchtefeld M; Schieffer B
Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
[TBL] [Abstract][Full Text] [Related]
14. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.
Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G
Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.
Epstein BJ; Gums JG
Ann Pharmacother; 2005 Mar; 39(3):470-80. PubMed ID: 15701766
[TBL] [Abstract][Full Text] [Related]
17. [Rational therapy of heart failure].
Werner MG; Schmieder RE
Z Kardiol; 1993; 82 Suppl 4():7-16. PubMed ID: 8147063
[TBL] [Abstract][Full Text] [Related]
18. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
19. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.
Jneid H; Moukarbel GV; Dawson B; Hajjar RJ; Francis GS
Am J Med; 2007 Dec; 120(12):1090.e1-8. PubMed ID: 18060931
[TBL] [Abstract][Full Text] [Related]
20. [ACE inhibitor or ATII receptor blocker in heart failure and myocardial infarction?].
Landmark K; Reikvam A
Tidsskr Nor Laegeforen; 2005 Jan; 125(1):38-40. PubMed ID: 15643463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
